BioSpace News Archive

Pharm Country

BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

BioSig Technologies, Inc. today announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, U.S. has signed a purchase agreement to acquire its PURE EP(T.M.) System.

July 7, 2022
·
6 min read
Drug Development

Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model

Galmed Pharmaceuticals Ltd. announced today results showing significant effects of Aramchol in pre-clinical model of both lung and gastrointestinal (GI) fibrosis.

July 7, 2022
·
6 min read
Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors

Inspira™ Technologies OXY B.H.N. Ltd. announced today that it has signed an exclusive summary distribution agreement with the U.S. based Glo-Med Networks (“Glo-Med”), for the distribution of the HYLA™ blood sensor device and disposable units across 6 states in the United States.

July 7, 2022
·
6 min read
FDA

Renovia receives FDA clearance for leva® Pelvic Health System as first-line treatment for chronic fecal incontinence

Renovia Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its leva ® Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI) in women.

July 7, 2022
·
6 min read
Biotech Bay

Coagulant Therapeutics Announces Publication of In Vivo Data Demonstrating Safety and Efficacy of CT-001 for the Management of Acute Bleeding

Coagulant Therapeutics Corporation today announced results from in vivo studies for its lead product candidate, CT-001, published in the July 2022 edition of the journal, Thrombosis Research.

July 7, 2022
·
5 min read
Biotech Bay

VistaGen to Participate at William Blair Biotech Focus Conference 2022

VistaGen to Participate at William Blair Biotech Focus Conference 2022.

July 7, 2022
·
4 min read
BioMidwest

Neogen Announces Pricing of $350.0 Million Senior Notes Offering and Entry into $800.0 Million Senior Secured Credit Agreement by Garden SpinCo Corporation

Neogen Corporation (“Neogen”) (NASDAQ: NEOG) announced today that on July 6, 2022 Garden SpinCo Corporation (“SpinCo”), a direct wholly-owned subsidiary of 3M Company (" 3M "), priced an offering of $350.0 million aggregate principal amount of 8.625% senior notes due 2030 (the “Notes”) in a private placement at par.

July 7, 2022
·
11 min read
Biotech Beach

Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform

Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced topline results from its recently completed study PM-611: Safety and Functionality Assessment of the Drug Delivery System (DDS) Capsule in humans.

July 7, 2022
·
6 min read
Pharm Country

Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has identified multiple unreported potential therapeutic targets for amyotrophic lateral sclerosis (ALS).

July 7, 2022
·
5 min read
BioCapital

Remidio’s Medios AI shows significant promise in last-mile Screening for Referable Glaucoma

Glaucoma, one of the world’s leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally.

July 7, 2022
·
3 min read